[1] Levels of fibrin monomers can be measured using blood tests and can serve as a marker of in vivo fibrinogenesis and coagulation activation.
[1][2][3] They may be useful in the evaluation of hypercoagulability, [1] as reflected in research studies done using fibrin monomers.
Levels of fibrin monomers may be increased with pregnancy[1] and by estrogen-containing combined birth control pills.
[2] Increased amount of soluble fibrin monomers in the blood along with serum D-dimers have been found to be indicators of venous thromboembolism (VTE).
[4][5] Detection of VTE in such a way have implications for treating VTE taking place during pregnancy and after hepatobiliary-pancreatic surgery.